A New Era of Genome Damage Response at the Forefront of Brain Disorders Therapy by Muralidhar L. Hegde, PhD, F-ABAP
From Viviana Vanegas on September 4th, 2020
Muralidhar L. Hegde, PhD, F-ABAP
Associate Professor, Department of Neurosurgery
Center for Neuroregeneration
Genome damage and defective repair are etiologically linked to neurodegeneration and brain hemorrhage. However, the specific mechanisms involved and their implications remain enigmatic, a roadblock for developing effective mechanism-based therapies. Our recent studies (Wang et al, Nature Communications, 2018; Mitra et al, PNAS, 2019; Guerrero et al, Hum Mol Gent, 2020; Dharmalingam et al, ACS Nano, 2020) uncovered novel mechanisms of DNA repair defects in motor neuron disease amyotrophic lateral sclerosis (ALS) and brain hemorrhage (ICH) patients, paving the way for DNA repair-targeted therapies to prevent or slow down disease progression. This research is supported by National Institutes of Health and Houston Methodist.
Recorded in the Houston Methodist Research Institute Ernest H. Cockrell Boardroom R2-311 on Wednesday, September 2, 2020.